Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Harrison, J. E.
Right arrow Articles by Blunt, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, J. E.
Right arrow Articles by Blunt, S. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Age and Ageing, Vol 29, 41-45, Copyright © 2000 by British Geriatrics Society

ARTICLES

Measuring symptom change in patients with Parkinson's disease

JE Harrison, S Preston and SB Blunt
CeNeS Ltd, Histon, Cambridge, UK. john.harrison@cenes.co.uk

BACKGROUND: The 39-item Parkinson's disease questionnaire (PDQ-39) is more sensitive to functional change than other measures of health and disability. AIM: To determine the ability of this scale to change over time and the concurrent validity of some of its subscales. METHODS: We assessed a cohort of 67 Parkinson's patients for 18 months, using the PDQ-39, the GHQ-28 general health questionnaire and the Office of Population and Census Surveys disability instrument. RESULTS: The Office of Population and Census Surveys disability instrument and GHQ- 28 recorded no significant change, but the PDQ-39 showed marked changes in levels of functioning. We also analysed changes on the PDQ-39 subscales as well as concurrent validity data for several subscales. This showed concurrent validity with the Beck depression and anxiety inventories, the Barthel index and the Royal Postgraduate Medical School severity scale. There was a high level of concurrent validity for all comparisons except for the Barthel index. CONCLUSION: The PDQ- 39 is a sensitive tool for monitoring change in patients with Parkinson's disease. It has high levels of concurrent validity with established measures of mood and motor function.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J Marinus, C Ramaker, J J van Hilten, and A M Stiggelbout
Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments
J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 241 - 248.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
G. L Creel, K. E Light, and M. T Thigpen
Concurrent and Construct Validity of Scores on the Timed Movement Battery
Physical Therapy, February 1, 2001; 81(2): 789 - 798.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.